| Management of hyperglycaemia in type 2 diabetes, 2018. A... |
258 |
| SGLT2 inhibitors and mechanisms of cardiovascular benefi... |
99 |
| Global trends in diabetes complications: a review of cur... |
98 |
| Class effects of SGLT2 inhibitors in mouse cardiomyocyte... |
75 |
| Diabetic cardiomyopathy: a hyperglycaemia- and insulin-r... |
69 |
| Trends and cyclical variation in the incidence of childh... |
62 |
| Effects of dapagliflozin and n-3 carboxylic acids on non... |
52 |
| Epidemiology of diabetes and diabetic complications in C... |
47 |
| The actions of SGLT2 inhibitors on metabolism, renal fun... |
47 |
| Gestational diabetes and the risk of cardiovascular dise... |
47 |
